Tigermed Closes Series A Financing and Enters Period of Rapid Expansion
Tigermed Consulting Co., Ltd. (“Tigermed”) announced today that it has successfully closed its Series A financing from Qiming Venture Partners, a premier venture capital firm based in Shanghai. With capital injection, Tigermed has entered into a period of rapid expansion. Tigermed is one of the largest Contract Research Organizations (CRO) in China, having played a [...]
China CRO attracts $30m US investment
China’s second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer.
Headquartered in Shanghai, the firm counts large pharma companies such as Eli Lilly amongst its customers and is now looking to aggressively expand its offerings beyond chemistry outsourcing, into “more [...]
China Trials 2009